Abstract
The advent of linear echoendoscopic ultrasound (EUS) in the 1990s has transformed EUS from a purely diagnostic modality to a platform for advanced diagnostic and therapeutic applications. The development of EUS-guided celiac ganglion neurolysis started a new era in EUS-guided techniques, where the fine needle has become the vehicle for delivery of various ablative agents, chemotherapeutic agents, and miniature devices. The following is an overview of recent advances and novel EUS-guided treatments of pancreatic tumors, including EUS-guided radiofrequency ablation, EUS-guided antitumor agents, and EUS-guided photodynamic therapy.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Fegrachi S, et al. Radiofrequency ablation for unresectable locally advanced pancreatic cancer: a systematic review. HPB (Oxford). 2014;16(2):119–23.
Goldberg SN, et al. EUS-guided radiofrequency ablation in the pancreas: results in a porcine model. Gastrointest Endosc. 1999;50(3):392–401.
Carrara S, et al. Endoscopic ultrasound-guided application of a new hybrid cryotherm probe in porcine pancreas: a preliminary study. Endoscopy. 2008;40(4):321–6.
Carrara S, et al. Endoscopic ultrasound-guided application of a new internally gas-cooled radiofrequency ablation probe in the liver and spleen of an animal model: a preliminary study. Endoscopy. 2008;40(9):759–63.
Petrone MC, et al. US-guided application of a new hybrid probe in human pancreatic adenocarcinoma: an ex vivo study. Gastrointest Endosc. 2010;71(7):1294–7.
Varadarajulu S, Jhala NC, Drelichman ER. EUS-guided radiofrequency ablation with a prototype electrode array system in an animal model (with video). Gastrointest Endosc. 2009;70(2):372–6.
Gaidhane M, et al. Endoscopic ultrasound-guided radiofrequency ablation (EUS-RFA) of the pancreas in a porcine model. Gastroenterol Res Pract. 2012;2012:431451.
Kim HJ, et al. EUS-guided radiofrequency ablation of the porcine pancreas. Gastrointest Endosc. 2012;76(5):1039–43.
Arcidiacono PG, et al. Feasibility and safety of EUS-guided cryothermal ablation in patients with locally advanced pancreatic cancer. Gastrointest Endosc. 2012;76(6):1142–51.
Pai M, et al. Endoscopic ultrasound guided radiofrequency ablation (EUS- RFA) for pancreatic ductal adenocarcinoma. Gut. 2013;62:A153.
Chang KJ, et al. Phase I clinical trial of allogeneic mixed lymphocyte culture (cytoimplant) delivered by endoscopic ultrasound-guided fine-needle injection in patients with advanced pancreatic carcinoma. Cancer. 2000;88(6):1325–35.
Mulvihill S, et al. Safety and feasibility of injection with an E1B-55 kDa gene-deleted, replication-selective adenovirus (ONYX-015) into primary carcinomas of the pancreas: a phase I trial. Gene Ther. 2001;8(4):308–15.
Hecht JR, et al. A phase I/II trial of intratumoral endoscopic ultrasound injection of ONYX-015 with intravenous gemcitabine in unresectable pancreatic carcinoma. Clin Cancer Res. 2003;9(2):555–61.
Hecht JR, et al. EUS or percutaneously guided intratumoral TNFerade biologic with 5-fluorouracil and radiotherapy for first-line treatment of locally advanced pancreatic cancer: a phase I/II study. Gastrointest Endosc. 2012;75(2):332–8.
Herman JM, et al. Randomized phase III multi-institutional study of TNFerade biologic with fluorouracil and radiotherapy for locally advanced pancreatic cancer: final results. J Clin Oncol. 2013;31(7):886–94.
Nakai Y, Chang KJ. Endoscopic ultrasound-guided antitumor agents. Gastrointest Endosc Clin N Am. 2012;22(2):315–24. x.
Irisawa A, et al. Endoscopic ultrasound-guided fine-needle injection of immature dendritic cells into advanced pancreatic cancer refractory to gemcitabine: a pilot study. Pancreas. 2007;35(2):189–90.
Dougherty TJ, et al. Photodynamic therapy. J Natl Cancer Inst. 1998;90(12):889–905.
Agostinis P, et al. Photodynamic therapy of cancer: an update. CA Cancer J Clin. 2011;61(4):250–81.
Bown SG, et al. Photodynamic therapy for cancer of the pancreas. Gut. 2002;50(4):549–57.
Huggett MT, et al. Phase I/II study of verteporfin photodynamic therapy in locally advanced pancreatic cancer. Br J Cancer. 2014;110(7):1698–704.
Yusuf TE, Matthes K, Brugge WR. EUS-guided photodynamic therapy with verteporfin for ablation of normal pancreatic tissue: a pilot study in a porcine model (with video). Gastrointest Endosc. 2008;67(6):957–61.
Hirooka Y, Itoh A, Kawashima H, Hara K, Nonogaki K, Kasugai T, Ohno E, Ishikawa T, Matsubara H, Ishigami M, Katano Y, Ohmiya N, Niwa Y, Yamamoto K, Kaneko T, Nieda M, Yokokawa K, Goto H. A combination therapy of gemcitabine with immunotherapy for patients with inoperable locally advanced pancreatic cancer. Pancreas. 2009;38(3):e69–74.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2016 Springer International Publishing Switzerland
About this chapter
Cite this chapter
Samarasena, J.B., Chang, K.J. (2016). Recent Advances and Novel Treatments of Pancreatic Masses. In: Wagh, M., Draganov, P. (eds) Pancreatic Masses. Springer, Cham. https://doi.org/10.1007/978-3-319-19677-0_24
Download citation
DOI: https://doi.org/10.1007/978-3-319-19677-0_24
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-19676-3
Online ISBN: 978-3-319-19677-0
eBook Packages: MedicineMedicine (R0)